These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 23982928)

  • 21. Novel sequence insertion in a Mâori patient with transfusion-dependent beta-thalassaemia.
    Blacklock HA; Case J; Chan T; Raizis T; Doocey R; Fellowes A; Royle G; Jackson S; Brennan S; George P
    Br J Haematol; 2005 Nov; 131(3):400-2. PubMed ID: 16225661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High incidence of osteoporosis in thalassaemia major.
    Jensen CE; Tuck SM; Agnew JE; Koneru S; Morris RW; Yardumian A; Prescott E; Hoffbrand AV; Wonke B
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():975-7. PubMed ID: 10091176
    [No Abstract]   [Full Text] [Related]  

  • 23. Coagulation disorders in dogs with hepatic disease.
    Prins M; Schellens CJ; van Leeuwen MW; Rothuizen J; Teske E
    Vet J; 2010 Aug; 185(2):163-8. PubMed ID: 19487141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A; Gumruk F; Gurgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major.
    Dimitriadou M; Christoforidis A; Economou M; Tsatra I; Vlachaki E; Fidani L; Katzos G; Athanassiou-Metaxa M
    Eur J Haematol; 2010 Jan; 84(1):64-71. PubMed ID: 19744128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of pregnancy in a patient with beta thalassaemia major.
    Butwick A; Findley I; Wonke B
    Int J Obstet Anesth; 2005 Oct; 14(4):351-4. PubMed ID: 16140004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Coagulation tests].
    Rasi V
    Duodecim; 1997; 113(13):1263-70. PubMed ID: 10622131
    [No Abstract]   [Full Text] [Related]  

  • 28. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
    Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E
    Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population.
    Ladis V; Chouliaras G; Berdoukas V; Chatziliami A; Fragodimitri C; Karabatsos F; Youssef J; Kattamis A; Karagiorga-Lagana M
    Eur J Haematol; 2011 Apr; 86(4):332-8. PubMed ID: 21288262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major.
    Saffar MJ; Saffar H; Khalilian AR; Naqshvar F
    East Mediterr Health J; 2009; 15(4):785-91. PubMed ID: 20187529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prolonged activated partial thromboplastin time at diagnosis indicates less favorable prognosis in IgA myeloma.
    Teng HW; Chen PM; Yang YH; Gau JP
    Jpn J Clin Oncol; 2007 Aug; 37(8):609-14. PubMed ID: 17693643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Idiopathic thrombocytopenic purpura complicated with circulating lupus anticoagulant].
    Saito K; Ishiyama T; Hashimoto M; Osawa H; Koike M; Sugimoto M; Horie S; Wakabayashi Y; Hirose S
    Rinsho Ketsueki; 1990 Jan; 31(1):52-6. PubMed ID: 2107346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum erythropoietin levels in pediatric patients with beta-thalassemia/hemoglobin E.
    Paritpokee N; Wiwanitkit V; Bhokaisawan N; Boonchalermvichian C; Preechakas P
    Clin Lab; 2002; 48(11-12):631-4. PubMed ID: 12465748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth and management of short stature in thalassaemia major.
    Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of the plasma phase of coagulation in platelet-rich plasma after passage through a special polyester filter].
    Cenni E; Arciola CR; Ciapetti G; Granchi D; Savarino L; Stea S; Cavedagna D; Falsone G; Mari G; Pizzoferrato A
    Minerva Med; 1993 Nov; 84(11):589-93. PubMed ID: 8015686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
    Ataga KI; Cappellini MD; Rachmilewitz EA
    Br J Haematol; 2007 Oct; 139(1):3-13. PubMed ID: 17854302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of beta-thalassaemia major in previously transfused patients.
    Ahmed S; Rehman ZU; Karamat KA
    J Coll Physicians Surg Pak; 2003 Jan; 13(1):19-21. PubMed ID: 12685969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders.
    Spiezia L; Campello E; Turatti G; Simion C; Fadin M; Gavasso S; Saggiorato G; Sartorello F; Zerbinati P; Simioni P
    Haemophilia; 2018 Nov; 24(6):e428-e430. PubMed ID: 30259602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.